{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:09:26Z","timestamp":1789362566565,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.049","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T23:49:00Z","timestamp":1498693740000},"page":"4112-4118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands"],"prefix":"10.1016","volume":"35","author":[{"given":"Stefan M.T.","family":"Vestjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan H.J.","family":"Wagenvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Meek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud F.","family":"Aldenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.M.","family":"Vlaminckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem Jan W.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ger T.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoudt M.W.","family":"van de Garde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2017.06.049_b0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2004.05.010","article-title":"Etiology of community-acquired pneumonia treated in an ambulatory setting","volume":"99","author":"Marrie","year":"2005","journal-title":"Respir Med"},{"issue":"9400","key":"10.1016\/j.vaccine.2017.06.049_b0010","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.vaccine.2017.06.049_b0015","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"issue":"9782","key":"10.1016\/j.vaccine.2017.06.049_b0020","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2017.06.049_b0025","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.049_b0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/CVI.00007-11","article-title":"Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone","volume":"18","author":"van Mens","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.06.049_b0035","unstructured":"van Lier, EA. Oomen, PJ. Giesbers, H. Drijfhout, IH. de Hoogh, PAAM. de Melker, HE. Vaccinatiegraad Rijksvaccinatieprogramma Nederland: Verslagjaar 2012. RIVM rapport 201001001 2012."},{"issue":"26","key":"10.1016\/j.vaccine.2017.06.049_b0040","first-page":"1454","article-title":"Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk","volume":"151","author":"de Greeff","year":"2007","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"8","key":"10.1016\/j.vaccine.2017.06.049_b0045","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.clinthera.2010.06.016","article-title":"Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands","volume":"32","author":"Rozenbaum","year":"2010","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.049_b0050","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","volume":"21","author":"Knol","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.049_b0055","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4161\/hv.24692","article-title":"Pneumococcal vaccination of older adults: conjugate or polysaccharide?","volume":"9","author":"Fedson","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.06.049_b0060","doi-asserted-by":"crossref","unstructured":"Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL, AGEDD Adult Pneumococcal Burden Study Team et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013;8(4):e60273.","DOI":"10.1371\/journal.pone.0060273"},{"issue":"28","key":"10.1016\/j.vaccine.2017.06.049_b0065","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/j.vaccine.2016.05.002","article-title":"Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly","volume":"34","author":"van Werkhoven","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.049_b0070","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.049_b0075","doi-asserted-by":"crossref","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","article-title":"Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis","volume":"7","author":"Spijkerman","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.049_b0080","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jamainternmed.2014.4344","article-title":"Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011","volume":"174","author":"Smith","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.vaccine.2017.06.049_b0085","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2006.10.018","article-title":"International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia","volume":"60","author":"van de Garde","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.06.049_b0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/00365540802014864","article-title":"Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia","volume":"40","author":"Endeman","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.06.049_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.06.049_b0100","series-title":"Modern Epidemiology","first-page":"258","article-title":"Chapter 15 Introduction to stratified analysis","author":"Rothman","year":"2008"},{"issue":"4","key":"10.1016\/j.vaccine.2017.06.049_b0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands","volume":"34","author":"Bosch","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.06.049_b0110","first-page":"E071213.1","article-title":"Local cluster of psittacosis after bird show in the Netherlands, November 2007.","volume":"12","author":"Koene","year":"2007","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2017.06.049_b0115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/CMR.00037-07","article-title":"Detection of respiratory viruses by molecular methods","volume":"21","author":"Mahony","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2017.06.049_b0120","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1086\/591392","article-title":"Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia","volume":"47","author":"Nolte","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.049_b0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"issue":"38","key":"10.1016\/j.vaccine.2017.06.049_b0130","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine"},{"issue":"9568","key":"10.1016\/j.vaccine.2017.06.049_b0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.049_b0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","article-title":"The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review","volume":"30","author":"Myint","year":"2013","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.049_b0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands","volume":"16","author":"Rodenburg","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.049_b0150","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"van Deursen","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.049_b0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk factors for community-acquired pneumonia in adults in Europe: a literature review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.vaccine.2017.06.049_b0160","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T14:00:38Z","timestamp":1569592838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17308423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17308423"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}